Metabolic Disorder Clinical Trial
Official title:
Analysis of Serum and Salivary ADMA-Arginine Levels in Patients With Periodontal and Cardiovascular Diseases
| NCT number | NCT03873948 |
| Other study ID # | 12-16 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | January 6, 2014 |
| Est. completion date | March 1, 2019 |
| Verified date | October 2019 |
| Source | University of Messina |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Asymmetric dimethylarginine (ADMA) plays a key role in endothelial function and may be a link for the known interaction of periodontitis and coronary heart disease (CHD). The investigators compared the impact of gingival health, periodontitis (CP), CHD or of both diseases (CP+CHD) on saliva and serum ADMA levels.
| Status | Completed |
| Enrollment | 141 |
| Est. completion date | March 1, 2019 |
| Est. primary completion date | August 8, 2018 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 19 Years to 75 Years |
| Eligibility |
Inclusion Criteria: - Presence of at least 16 teeth - CP with a minimum of 40% of sites with a clinical attachment level (CAL) =2mm and probing depth (PD) =4mm; - Presence of at least =2 mm of crestal alveolar bone loss verified on digital periapical radiographs - Presence of =40% sites with bleeding on probing (BOP) Exclusion Criteria: - Intake of contraceptives - Intake of immunosuppressive or anti-inflammatory drugs throughout the last three months prior to the study - Status of pregnancy or lactation - Previous history of excessive drinking - Allergy to local anaesthetic - Intake of drugs that may potentially determine gingival hyperplasia such as Hydantoin, Nifedipine, Cyclosporin A or similar drugs. |
| Country | Name | City | State |
|---|---|---|---|
| Italy | University of Messina | Messina |
| Lead Sponsor | Collaborator |
|---|---|
| University of Messina |
Italy,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Clinical Attachment level | 1 year |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00546052 -
A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)
|
Phase 3 | |
| Completed |
NCT02650674 -
Determination of the Glycaemic Index and Insulinaemic Index Values of Five Cereal Products
|
N/A | |
| Completed |
NCT00707746 -
Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects
|
Phase 2 | |
| Completed |
NCT02573103 -
Air Pollution and Cardiovascular Disease
|
||
| Not yet recruiting |
NCT06051461 -
Deciphering the Role of Dietary Fatty Acids on Extracellular Vesicles-mediated Intercellular Communication
|
N/A | |
| Not yet recruiting |
NCT05013112 -
Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT)
|
N/A | |
| Enrolling by invitation |
NCT04654000 -
Rheopheresis as Adjuvant Treatment of Calciphylaxis
|
N/A | |
| Completed |
NCT01337141 -
A Telematic Program for Optimization of Metabolic Control in Diabetes Mellitus Type 1 (DM1) Patients
|
N/A | |
| Completed |
NCT00477594 -
Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
|
Phase 2 | |
| Recruiting |
NCT03882580 -
Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
|
||
| Active, not recruiting |
NCT01911091 -
Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)
|
N/A | |
| Completed |
NCT00607373 -
Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia
|
Phase 3 | |
| Completed |
NCT00362180 -
Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
|
Phase 2 | |
| Completed |
NCT01738061 -
A Multidimensional Lifestyle Intervention to Reduce the Risk of Metabolic Disorders in Older Workers in Taiwan
|
N/A | |
| Completed |
NCT02059993 -
The Effects of Obstructive Sleep Apnea and Its Intervention on Coronary Heart Disease
|
N/A | |
| Completed |
NCT06129578 -
Plant Protein Supplementation Within a Healthy Lifestyle Modulates Plasma Circulating Amino Acids and Improves the Health Status of Overweight Individuals
|
N/A | |
| Completed |
NCT06331572 -
Exploring Blood Plasma Metabolomics: Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression
|
||
| Completed |
NCT05255718 -
Impact of Aronia Berry Consumption on Inflammation, Metabolites, and the Gut Microbiome
|
N/A | |
| Completed |
NCT00694109 -
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
|
Phase 3 |